Hamid Ali Nagi Al‐Jamal

Association of ABO blood groups with diabetes mellitus

Muhammad Kamil, Hamid Ali Nagi Al‐Jamal, Narazah Mohd Yusoff · Libyan Journal of Medicine · 2010 · 70 citations · Full text

Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia

Hamid Ali Nagi Al‐Jamal, Siti Asmaa Mat Jusoh, Rosline Hassan et al. · BMC Cancer · 2015 · 49 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +22

Gene Expression Profiling and Protein Analysis Reveal Suppression of the C-Myc Oncogene and Inhibition JAK/STAT and PI3K/AKT/mTOR Signaling by Thymoquinone in Acute Myeloid Leukemia Cells

Belal Almajali, Muhammad Farid Johan, Abdullah Saleh Al-wajeeh et al. · Pharmaceuticals · 2022 · 28 citations · Full text

C-myc Expression, Mixed-phenotype Acute Leukemia, Immunology +25

Determination of optimum incubation time for formation of Pseudomonas aeruginosa and Streptococcus pyogenes biofilms in microtiter plate

Mohammad A. Al-kafaween, Abu Bakar Mohd Hilmi, Norzawani Jaffar et al. · Bulletin of the National Research Centre/Bulletin of the National Research Center · 2019 · 25 citations · Full text

Silencing of Suppressor of Cytokine Signaling-3 due to Methylation Results in Phosphorylation of STAT3 in Imatinib Resistant BCR-ABL Positive Chronic Myeloid Leukemia Cells

Hamid Ali Nagi Al‐Jamal, Siti Asmaa Mat Jusoh, Ang Cheng Yong et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 24 citations · Full text